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Background: Overtraining syndrome (OTS), functional (FOR) and non-functional overreaching (NFOR) are conditions
diagnosed in athletes with decreased performance and fatigue, triggered by metabolic, immune, hormonal and other
dysfunctions and resulted from an imbalance between training stress and proper recovery. Despite previous descriptions,
there is a lack of a review that discloses all hormonal findings in OTS/FOR/NFOR. The aim of this systematic review is to
evaluate whether and which roles hormones play in OTS/FOR/NFOR.
Methods: A systematic search up to June 15th, 2017 was performed in the PUBMED, MEDLINE and Cochrane databases
following PRISMA protocol, with the expressions: (1)overtraining, (2)overreaching, (3)overtrained, (4)overreached,
or (5)underperformance, and (plus) (a)hormone, (b)hormonal, (c)endocrine, (d)adrenal, (e)cortisol, (f)GH, (g)ACTH,
(h)testosterone, (i)IGF-1, (j)TSH, (k)T4, (l)T3, (m)LH, (n)FSH, (o)prolactin, (p) IGFBP-3 and related articles.
Results: A total of 38 studies were selected. Basal levels of hormones were mostly normal in athletes with OTS/
FOR/NFOR compared with healthy athletes. Distinctly, stimulation tests, mainly performed in maximal exercise
conditions, showed blunted GH and ACTH responses in OTS/FOR/NFOR athletes, whereas cortisol and plasma
catecholamines showed conflicting findings and the other hormones responded normally.
Conclusion: Basal hormone levels are not good predictor but blunted ACTH and GH responses to stimulation tests may
be good predictors of OTS/FOR/NFOR.
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Overtraining syndrome (OTS) and related states are
results of a combination between excessive overload in
training stress and inadequate recovery, which leads to
acute feelings of fatigue and decreases in performance
[1]. The whole spectrum of underperformance condi-
tions includes: a. functional overreaching (FOR), when
there is a very short-term (days to few weeks) decrement
in performance and supercompensation (improvement in
performance) after recovery [1]; b. non-functional over-
reaching (NFOR), when performance worsens for a short
period (but longer than FOR, between weeks to months)
and a full recovery (although not always the previous
performance capacity is reestablished) is observed after
proper recovery period [1]; and c. overtraining syndrome* Correspondence: kater@unifesp.br
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(http://creativecommons.org/publicdomain/ze(OTS), when a long-term (usually several months but
can be indefinitely) decrement in performance capacity
allied to psychological symptoms are seen [1]. Despite of
these descriptions, it is unfeasible to set an unquestion-
able definition and precise limits between OTS, NFOR
and FOR.
The imbalance between training and recovery, which can
be worsened or confounded by inadequate nutrition, illness,
psychosocial stressors and sleep disorders [1], among many
other causes, leads to dysfunction of pathways and
responses in immune, inflammatory, neurological, hormonal
and metabolic systems as a maladaptation to chronic expos-
ure to extreme metabolic and tissue environments. This
includes, for instance, chronic glycogen depletion (although
normal levels of glycogen are found at the moment of the
examination of athletes).
There are apparently no reliable or accurate biomarkers
that help diagnose OTS/NFOR/FOR, even though dimin-
ished maximal lactate concentration, creatine kinase alteredle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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creased plasma glutamine levels have been found [1].
Despite of the efforts to find tools to improve diagnosis
of OTS/NFOR/FOR, these have not yet been successful.
Regarding the current literature on endocrine aspects
of OTS/NFOR/FOR, basal (resting) hormone measure-
ments cannot distinguish between athletes who successfully
adapt to FOR and those who fail to adapt and develop
symptoms of OTS, although a diminished hormone reserve
and consequent impairment of hormone response to acute
stressful situations may be one of the triggers of OTS/
NFOR/FOR symptomatology, particularly the worsened
performance, the key symptom of any underperformance
syndrome. Regarding hormonal aspects of OTS/NFOR/
FOR, the latest guideline [1] on OTS/NFOR/FOR recom-
mends that further studies are recommended to discover
possible hormonal diagnostic tests [1].
Therefore, to determine if and which basal or stimulated
hormonal markers can be successfully linked to OTS/
NFOR/FOR and which are the most accurate predictors is
the aim of this systematic review. The primary outcomes
are an evaluation of methodology for the assessment of
overtraining, a comparison of hormonal tests performed
and analysis of results of studies involving correlation
between hormones and OTS/NFOR/FOR.Methods
Search strategies
To provide a wide, complete and thorough systematic
review over hormonal aspects in OTS/NFOR/FOR, PRISMA
protocol for systematic reviews was used for the study design
and a systematic search was conducted through the
electronic PUBMED, MEDLINE (Ebsco), and COCHRANE
databases, from their earliest records to November 8th,
2017. Searched expressions were: (1)overtraining, (2)over-
reaching, (3)overtrained, (4)overreached or (5)underper-
formance, and (plus) (a) hormone, (b) hormonal, (c)
endocrine, (d) adrenal, (e) cortisol, (f) GH, (g) ACTH, (h)
testosterone, (i) IGF-1, (j) TSH, (k) T4, (l) T3, (m) LH, (n)
FSH, (o) prolactin and (p) IGFBP-3, in a total of 85 ex-
pressions searched.
We also analyzed articles that were mentioned within
identified studies whenever OTS/NFOR/FOR or a similar
disorder was described (e.g. cortisol and adrenocorticotropic
hormone (ACTH) profiles and over-trained athletes).Data extraction
All studies were evaluated after removal of duplicate
articles, according to: 1) authorship, 2) publication date, 3)
studied population, 4) definition of overtraining and over-
reaching syndromes, 6) study design and methods, 7)
methods of hormone assessment, 8) results, 9), conclu-
sions and 10) study variables and bias.Eligibility criteria
Inclusion criteria were: 1) whole article written in English;
2) hormone profile (basal, stimulated, or both) and correl-
ation to OTS/NFOR/FOR states as an outcome (but not
necessarily the primary outcome); 3) absence of influence
of any hormone therapy; 4) absence of confounding dis-
eases that would lead to an impaired hormonal status
caused by the disorder itself, which would also exclude the
diagnoses of OTS/NFOR/FOR; 5) population with proper
diagnosis of OTS/NFOR/FOR; and 6) studies with humans.
Quality assessment
The abstract of each of researched study was analyzed
by one of the authors (F.A.C.) and assessed for inclusion
according to the eligibility criteria. The studies that
fulfilled the inclusion criteria were evaluated with regard
to their rationale, study design, primary outcomes, assess-
ment of OTS/NFOR/FOR diagnosis, statistical analysis,
results, discussion and conclusions. Studies that presented
any bias in methodology, results, or interpretation of the
exposed data, that could interfere in the analysis were ex-
cluded. Studies whose methodology could not be assessed
by the abstract had the full text analyzed, prior to the deci-
sion of the acceptance for the systematic review.
Statistical analysis
Due to the heterogeneity of the studies that aim to correlate
hormone responses and OTS/NFOR/FOR, a meta-analysis,
our initial idea, was unfeasible. Moreover, since several vari-
ables were taken into account, including the type of sports
performed, type of tests and stimulus performed, and
whether hormones were analyzed basally, and during a
resting period or resting after an intensive training load,
analysis of each aspect was performed separately, and
in several different combinations, including studies that per-
formed equivalent methods, although not similar, including
all tests stimulated by exercises, regardless of the type of
stimulation, tests performed in endurance sports, regardless
of the type of sport, and resting combined with basal hor-
mones, regardless of the previous exercise stimulation. Data
was also analyzed according to the number of studies inves-
tigating each type of sport, the number of athletes with
OTS/NFOR/FOR and healthy athletes, and the number of
studies using each type of hormone stimulation test were
quantified. Study results were analyzed in terms of percent-
age of type of responses for each of the tests performed.
Once meta-analysis was not performed, t-tests, one-way
ANOVA and non-parametric tests were not employed, and
therefore a statistical analysis program was not necessary.
Results
Selection of the studies
The initial search yielded 835 articles. The sum of the
searches for “overtraining”, “overreaching”, “overtrained”,
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cholamines” yielded 62 articles; 2. With “ACTH” yielded
29 articles; 3. with “cortisol” yielded 161 articles; 4. with
“adrenal” yielded 60 articles; 5. “GH” yielded 13 results;
6. with “IGF-1” yielded 19 articles; 7. with “IGFBP-3”
yielded four articles; 8. with “testosterone” yielded 100
articles; 9. with “LH” yielded nine articles; 10. with
“FSH” yielded four articles; 11. with “TSH” yielded four
articles; 12. with “T4” yielded 12 articles; 13. with “T3”
yielded 13 articles; 14. with “prolactin” yielded 10 arti-
cles; 15.with “hormone” yielded 195 articles; 16. with
“hormonal” yielded 92 articles; and 17. with “endocrine”
yielded 49 articles.
However, 612 studies were yielded in more than one
search, while 185 did not meet criteria to be included in
this systematic review. None of the studies were in a
language other than English. Ultimately 38 articles were
included for analysis in this systematic review [2–38]
(detailed in Table 1), representing 4.59% of the original
search results. Two studies [34, 35] were included in the
same analysis as both analyzed different hormones in
the same subjects, in both moments.
Among the yielded articles, the reasons of the exclu-
sions were due to: (1) Review of FOR/NFOR/OTS – 57
articles; (2) Performed in animals – 35 articles; (3)
Nutritional supplementation for FOR/NFOR/OTS – 20
articles; (4) Hormonal physiological adaption to exer-
cises – 13 articles; (5) Other markers of FOR/NFOR/
OTS than not hormones – 14 studies; (6) Markers of
stress during training – 09 articles; (7) Other dysfunc-
tions than FOR/NFOR/OTS evaluated (depression,
amenorrhea) – 06 studies; (8) Nutritional management
of FOR/NFOR/OTS – 06 studies; (9) Improper criteria
for diagnosis of FOR/NFOR/OTS – 05 articles; (10)
Stimulation therapies effects on FOR/NFOR/OTS (elec-
trical, cryotherapies) – 04 articles; (11) Post-hoc analysis –
03 articles; (12) Non-FOR/NFOR/OTS review – 03 articles;
(13) Training management for FOR/NFOR/OTS – 02
articles; (14) Predictive markers of FOR/NFOR/OTS – 02
articles; (15) Pre-stressful events hormonal alterations – 02
articles; (16) Markers of competition performance (but not
for FOR/NFOR/OTS) – 01 article; (17) Non-hormonal
adaptions to exercise – 01 article; (18) Non-sport FOR/
NFOR/OTS – 01 article; (19) In-vitro study – 01 article;
and (20) Guideline – 01 article. The total of excluded arti-
cles that were not due to duplication were 179 studies,
which means among the non-duplicate yielded articles,
82.5% were excluded, whereas 38 (17.5%) were included.
Study characteristics
Sports performed
Among the 38 studies [2–38], six were performed with
cyclists, six with triathlon athletes, four with medium
distance runners, four with rugby players, three with longdistance runners, three with swimmers, three with weight-
lifters, three with in military-related physical activities par-
ticipants, two with soccer players, two with rowing athletes,
one in motocross riders, one with short distance runners,
one with orienteers, one with skiers, one with tennis
players, one with skaters, one with American football
players and one with volleyball players (Table 2). Among
these studies, six involved more than one modality, whereas
two studies did not specify the sports performed in the
manuscript. The median number of tested athletes in the
38 studies was 14 (range: 3–36).
Type of studied athletes and control group
Among the 38 selected studies, 21 (55.2%) were per-
formed in healthy athletes that were induced NFOR/
FOR state, while 17 (44.7%) were employed in previously
affected athletes; among the 17 articles made with OTS/
NFOR/FOR athletes, three (7.9% of total studies) per-
formed an Overload Training Program (OTP) in order to
worsen the underperformance state, whereas 14 (36.8%)
evaluated hormone levels without an OTP.
From the selected studies, 26 (68.4%) had a control
group of healthy athletes, whereas 12 (31.6%) compared
with previous or basal levels of the same athletes.
Type of performed tests
Among the 38 selected studies, 24 (63.2%) evaluated
resting hormone levels after an induced NFOR/FOR
state, 17 (44.7%) tested basal hormone levels and 16
(42.1%) evaluated acute hormone responses to stimula-
tion tests. Among these, nine (23.7%) evaluated both
basal and stimulated hormones, whereas seven (18.4%)
tested both acute hormone responses to functional tests
and resting levels after an overload training program.
Induction of NFOR/FOR state in healthy athletes was
performed either by an OTP (22 studies) or after a Com-
petition Season Period (CSP) (three studies), followed by
a proper diagnosis of OTS/NFOR/FOR (reduction of at
least 10% of the previous performance). One study [3]
performed both OTP and CSP.
Conversely, among the stimulation tests performed in
previously affected athletes, 11 (68.8% of all stimulation
tests) were carried out with maximal exercise (ME), three
(18.8%) with two-bout protocol exercises (TBE) and two
(12.5%) with an insulin tolerance test (ITT). Seven of the
studies performed two types of stimulation tests.
Five studies [10, 28, 30, 35, 36] performed both resting
levels after an OTP and hormones responses to ME in
NFOR/FOR induced athletes by OTP, one [19] performed
both basal and stimulated hormones by ITT, and one [18]
performed ME response after an OTP, but not basal levels;
the seven studies that explored acute responses after an
OTP means 33.3% of total of studies that performed OTP;
the six studies that performed ME after an OTP represents
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Table 2 Number of studies performed in each sport
Sport performed Number
of studies
Sport performed Number
of studies
Triathlon 6 Short distance running 1
Cycling 6 Orienting 1
Rugby 4 Motocross 1
Middle distance running 4 Tennis 1
Weight-lifting 3 Skating 1
Long distance running 3 American Football 1
Swimming 3 Karate 1
Multiple military activities 3 Volleyball 1
Soccer 2 More than one sport 6
Rowing 2 Not specified in
manuscript
1
Skiing 1
Cadegiani and Kater BMC Sports Science, Medicine and Rehabilitation  (2017) 9:14 Page 6 of 1554.6% of total studies that employed ME, as the other
studies did ME in previously affected athletes without
any previous type of overload training. Figure 1 sum-
marizes the types of athletes and tests performed in the
selected studies.
Regarding the object of comparison for analysis purposes,
20 studies (52.6%) compared resting hormone levels of
FOR-induced athletes by OTP/CSP with previous resting
levels; 18 (47.4%) compared basal levels of affected athletes
with basal levels of healthy athletes; 12 (31.6%) compared
acute hormone responses to stimulation tests between af-
fected and healthy athletes; 11 (28.9%) compared compared
resting hormone levels of FOR-induced athletes with rest-
ing levels of healthy athletes; and four (10.5%) compared
acute hormone response to stimulation tests with basal
levels of the same affected athletes. From the 38 studies, 21
(55.2%) performed more than one type of comparison (eg.
Analysis between basal levels of the same affected athletes
and also between affected and healthy athletes).Fig. 1 Types of selected athletes and tests performedHormone findings from the selected studies
Basal hormones levels
A total of 17 studies (44.7%) compared basal hormone
levels between affected and healthy athletes; all hormones
and other analyzed parameters disclosed normal levels, as
detailed in Table 3.Resting hormone levels in NFOR/FOR-induced athletes
A total of 24 studies (63.2%) measured resting hormones
of NFOR/FOR-induced athletes and are displayed in
Table 4; normal levels were observed in almost all hor-
mones, including the most performed ones: cortisol (75.0%
of the findings in 16 studies) and total testosterone (total T)
(66.7% of the results in 15 studies), but altered findings
were found in testosterone/cortisol ratio (T/C), which has
been performed in 10 studies and disclosed reduced ratios
in 50.0% of these studies, and in night urinary catechol-
amines (NUC), which disclosed increased levels in 50.0% of
four studies.
Finally, T/C and NUC were the only parameters that
showed altered levels (reduced T/C and increased NUC)
compared to the healthy periods of the athletes.Joint analysis of basal hormone levels and resting hormone
levels in NFOR/FOR-induced athletes
For a better comprehension of the findings, studies with
basal levels were clustered with studies that performed
resting levels of induced NFOR/FOR state in athletes,
once both groups present similar diagnosis, regardless of
the path (if previously affected or if induced during the
study) that led them to the OTS/NFOR/FOR states.
Therefore, when analyzed together, basal hormones of
previously affected athletes and resting hormones of
NFOR/FOR induced subjects displayed normal findings
in all parameters, as observed in Table 5.
Table 3 Basal hormone levels
Hormone Quantity of studies Normal levels Reduced levels Increased levels
ACTH 7 (41.2%) 5 (71.4%) - 2 (28.6%)
Cortisol 6 (35.3%) 4 (66.7%) 1 (16.1%) 1 (16.1%)
GH 5 (29.4%) 3 (60.0%) 1 (20.0%) 1 (20.0%)
NUC 4 (23.5%) 3 (75.0%) 1 (25.0%) -
IGF-1 2 (11.8%) 2 (100%) - -
Total T 2 (11.8%) 1 (50.0%) 1 (50.0%) -
Plasma Catecholamines 2 (11.8%) 1 (50.0%) - 1 (50.0%)
Prolactin 2 (11.8%) 2 (100%) - -
T/C ratio 2 (11.8%) 2 (100%) - -
Insulin 1 1 - -
SHBG 1 - - 1
Aldosterone 1 1 - -
T/SHBG 1 1 - -
Free T 1 1 - -
IGFBP-3 1 - 1 -
IGF-1/IGFBP-3 1 - - 1
Peptide F 1 1 - -
4 PM salivary C 1 - - 1
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin; salivary C salivary cortisol, 4 PM salivary
C salivary cortisol collcted at 4 PM, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio
Cadegiani and Kater BMC Sports Science, Medicine and Rehabilitation  (2017) 9:14 Page 7 of 15Acute hormone responses to stimulation tests
Regarding acute stimulated hormonal levels in 16 studies
(42.1%), the most employed hormones were cortisol (11
studies), ACTH (seven studies) and 3. GH (seven studies.
The detailed findings are shown in Table 6.
Herein, GH, ACTH and prolactin shows undoubtedly
blunted responses to most acute stressful tests, despite
of the small number of studies and subjects evaluated,
whereas other hormones show normal findings.
Joint analysis of resting hormone levels in NFOR/FOR-induced
athletes and acute hormone responses to stimulation tests
Acute hormone responses to stimulation tests can also
be analyzed together with resting hormone levels after
an OTP, once both explore capacity to respond to stressful
situations. When acute hormones responses were analyzed
together with the resting levels of induced NFOR/FOR, the
only marker that showed mostly altered levels was aldoster-
one. However, contradictory findings were observed since
half of the altered results were increased whereas half were
decreased. Detailed findings are displayed in Table 7.
Hormonal levels of the type of athletes (if previously
healthy or affected by OTS/NFOR/FOR)
Whether athletes were previously affected by OTS/
NFOR/FOR or if they were previously healthy and were
induced to NFOR/FOR states by an OTP or CSP may be
meaningful to the hormone findings. Table 8 shows thehormonal results according to the type of selected athletes,
regardless of being basal, resting or acutely stimulated, once
the objective in this section is to evaluate hormone levels as
a whole in previously affected compared to previously
healthy athletes. For analysis purposes, we considered only
hormones that have been performed by more than one
study While 14 out of 16 hormones (87.5%) were mostly
normal in FOR-induced athletes, five from 12 hormones
(41.7%) disclosed mostly normal levels and responses when
OTS-affected athletes were analyzed.
Discussion
Systematic search
The aim of this systematic review is to evaluate hormonal
aspects of OTS/NFOR/FOR already published. Therefore,
after the search for a wide number of expressions and
hormones, only 38 met the criteria, as many expressions
yielded the same studies. Moreover, 82.5% of the studies
were descriptive, did not perform hormone tests, or there-
fore did not add new information or evidence to correl-
ation between OTS/NFOR/FOR and hormone profile.
The systematic search was expanded beyond the PRISMA
guidelines for systematic reviews in order to achieve all
the studies that correlate hormone levels and OTS/
NFOR/FOR, due to the wide variety of expressions and
study designs.
As stated in the results section, it was unfeasible to
analyze each sport separately due to the small number
Table 4 Resting levels after overload training (OTP or CSP)
Parameter Quantity of studies Normal response Blunted response Exacerbated response
Cortisol 16 (66.7%) 12 (75.0%) 4 (25.0%)
Total T 15 (62.5%) 10 (66.7%) 4 (26.7%) 1 (6.7%)
T/C 10 (41.7%) 4 (40.0%) 5 (50.0%) 1 (10.0%)
Plasma catecholamines 6 (25.0%) 4 (66.7%) 2 (33.3%) -
Insulin 5 (20.8%) 4 (80.0%) 1 (20.0%) -
LH 5 (20.8%) 4 (80.0%) 1 (20.0%) -
FSH 4 (16.7%) 3 (75.0%) 1 (25.0%) -
GH 4 (16.7%) 2 (50.0%) 1 (25.0%) 1 (25.0%)
IGF-1 4 (16.7%) 3 (75.0%) 1 (25.0%) -
NUC 4 (16.7%) 1 (25.0%) 1 (25.0%) 2 (50.0%)
Free T 3 (12.5%) 1 (33.3%) 1 (33.3%) 1 (33.3%)
ACTH 3 (12.5%) 3 (100.0%) - -
Aldosterone 3 (12.5%) 1 (33.3%) 1 (33.3%) 1 (33.3%)
T4 2 (8.3%) 2 (100.0%) - -
T3 2 (8.3%) 2 (100.0%) - -
TSH 2 (8.3%) 2 (100.0%) - -
Prolactin 2 (8.3%) 2 (100.0%) - -
Salivary C 2 (8.3%) - 2 (100.0%) -
Salivary T 2 (8.3%) 1 (50.0%) 1 (50.0%) -
Peptide C 2 (8.3%) 2 - -
IGFBP-3 1 1 - -
IGF-1/IGFBP-3 1 1 - -
DHEA-S 1 1 - -
Peptide F 1 1 - -
Fertility 1 - 1 -
SHBG 1 1 - -
Beta-2 muscle receptors 1 - 1 -
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin, T3 thyronine, T4 thyroxine, salivary C salivary
cortisol, salivary T salivary testosterone, 4 PM salivary C salivary cortisol collcted at 4 PM, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio, fertility evaluation by semen analysis
Cadegiani and Kater BMC Sports Science, Medicine and Rehabilitation  (2017) 9:14 Page 8 of 15of subjects of each study, wide distribution of sports
performed, heterogeneity regarding most aspects of the
studies, such as inclusion criteria, and precise definition
of who were affected by OTS/NFOR/FOR.
Interestingly, more reviews on hormonal aspects of OTS/
NFOR/FOR were found (55 reviews) than the number of
selected studies (44.7% more than original articles). More-
over, five studies improperly diagnosed OTS/NFOR/FOR
based on hormones alterations, such as reductions of 30%
or more of T/C ratio, regardless of the performance status.
Types of parameters and tests performed
There were three types of assessed hormones: 1. basal
hormones in previously affected athletes; 2. resting levels
after an overload training; and 3. acute hormone responses
to stimulation tests in OTS/NFOR/FOR individuals.
Among the 38 selected studies, 26 different hormones
and hormone-related parameters were assessed, both basallyand stimulated. Interestingly, the stimulation tests per-
formed were not those recommended by endocrine
societies and have not been validated previously, except
two, that performed ITT; indeed, the oldest study found
by this systematic review, performed by Barron et al. [38]
and published in 1985 performed ITT and found blunted
ACTH and cortisol levels in OTS/NFOR athletes; how-
ever, no further studies that tried to reproduce these
findings were found. ITT is a gold-standard functional
test recommended by Endocrine societies to evaluate
stress hormone response to a simulation of a stressful
situation, the hypoglycemia. This test requires the whole
axis integrity in order to provide normal responses;
and, regardless of the affected level of each axis, the
lack of response mimic the real-life stressful situations,
which may lead to decreased performance in extreme
sports sessions, when integrity of stress-related axis are
required.
Table 5 Joint of basal with resting hormone levels of athletes induced for NFOR/FOR by overload training
Hormone Quantity of studies (% of total basal and resting levels) Normal levels (%) Reduced levels (%) Increased levels (%)
Cortisol 22 (53.7%) 16 (72.7%) 5 (22.7%) 1 (4.6%)
Total T 17 (41.5%) 11 (64.7%) 5 (29.4%) 1 (5.9%)
T/C ratio 12 (29.3%) 6 (50.0%) 5 (41.7%) 1 (8.3%)
ACTH 10 (24.4%) 8 (80.0%) - 2 (20.0%)
GH 9 (21.9%) 5 (55.6%) 2 (22.2%) 2 (22.2%)
NUC 8 (19.5%) 4 (50.0%) 2 (25.0%) 2 (25.0%)
Plasma Catecholamines 8 (19.5%) 5 (62.5%) 2 (25.0%) 1 (12.5%)
IGF-1 6 (14.6%) 5 (83.3%) 1 (16.7%) -
Insulin 6 (14.6%) 5 (83.3%) 1 (16.7%) -
LH 5 (12.2%) 4 (80.0%) 1 (20.0%) -
FSH 4 (9.8%) 3 (75.0%) 1 (25.0%) -
Free T 4 (9.8%) 2 (100%) 1 (25.0%) 1 (25.0%)
Aldosterone 4 (9.8%) 2 (50.0%) 1 (25.0%) 1 (25.0%)
Prolactin 4 (9.8%) 4 (100%) - -
TSH 2 (4.9%) 2 (100%) - -
T4 2 (4.9%) 2 (100%) - -
T3 2 (4.9%) 2 (100%) - -
SHBG 2 (4.9%) 1 (50.0%) - 1 (50.0%)
IGFBP-3 2 (4.9%) 1 (50.0%) 1 (50.0%) -
IGF-1/IGFBP-3 2 (4.9%) 1 (50.0%) - 1 (50.0%)
Peptide F 2 (4.9%) 2 (100%) - -
Salivary C 2 (4.9%) - 2 (100%) -
Salivary T 2 (4.9%) 1 (50.0%) 1 (50.0%) -
T/SHBG 1 1 - -
4 PM salivary C 1 - - 1
Fertility 1 - 1 -
Beta-2 muscle receptors 1 - 1 -
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin, T3 thyronine, T4 thyroxine, salivary C salivary
cortisol, salivary T salivary testosterone, 4 PM salivary C salivary cortisol collcted at 4 PM, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio, fertility evaluation by semen analysis
Cadegiani and Kater BMC Sports Science, Medicine and Rehabilitation  (2017) 9:14 Page 9 of 15Although not supported by Endocrine societies, some
authors showed that hormonal responses to intense
exercises (ME) seemed to be more appropriate to evalu-
ating OTS/NFOR/FOR, which is confirmed by the find-
ings of this systematic review. Thus five different kinds
of stimulation tests were used for the evaluation of hormo-
nal responsiveness, including three that evaluated acute
response tests (ME, TBE and ITT), and two that measured
in resting after a training overload (OTP and CSP). Accord-
ing to the most recent OTS/NFOR/FOR guidelines [1], the
most cited test among the reviewed studies was TBE;
however, we observed that ME, and not TBE, was the most
studied functional test, and was able to show significant dif-
ferences between OTS/NFOR/FOR and healthy athletes.
However, none of the studies established a proposed cutoff
for any of the tested hormones, and most of the conclu-
sions recommend further studies to establish validated
cutoff and criteria.The heterogeneity of ME protocols, the lack of cutoff for
the tests hormones (despite of the altered hormone find-
ings), and the small number of participants in most studies
(as it is not easy to recruit athletes affected with OTS/
NFOR/FOR in the current moment of the disease) lead to
the fact that is is possibl but uncertain whether the con-
ducted tests are useful for the accurate diagnosis of OTS/
NFOR/FOR. Further studies should explore the findings of
this systematic review and perform validated tests by
Endocrine societies, such as ITT, and standardized tests by
the latest guideline [1], such as TBE, and provide correl-
ation between responses of thes two types of tests, as well
as attempt to establish reliable cutoffs for each hormone in
order to provide a new biomarker for OTS/NFOR/FOR.
Types of sports practiced
OTS/NFOR/FOR related to endurance sports was ana-
lyzed by 35 (92.1%) studies, whereas resistive exercises
Table 6 Hormone responses to acute stress (ME, TBE and ITT)
Parameter Quantity of studies (% of stimulation tests) Normal response Blunted response Exacerbated response
Cortisol 10 (62.5%) 5 (50.0%) 5 (50.0%) -
ACTH 7 (43.7%) 3 (42.9%) 4 (57.1%) -
GH 7 (43.7%) 3 (42.9%) 4 (57.1%) -
Total T 4 (25.0%) 3 (75.0%) 1 (25.0%) -
Plasma catecholamines 3 (18.7%) - 2 (66.7%) 1 (33.3%)
Prolactin 3 (18.7%) 1 (33.3%) 2 (67.1%) -
Insulin 3 (18.7%) 2 (67.1%) 1 (33.3%) -
LH 3 (18.7%) 3 (100.0%) - -
T/C 3 (18.7%) 1 (33.3%) 1 (33.3%) 1 (33.3%)
FSH 2 (12.5%) 2 - -
IGF-1 2 (12.5%) 1 - 1
LH 2 (12.5%) 2 - -
FSH 2 (12.5%) 2 - -
Salivary C 2 (12.5%) - 2 -
Salivary T 2 (12.5%) 1 1 -
Aldosterone 2 (12.5%) - 1 1
IGFBP-3 1 - 1 -
IGF-1/IGFBP-3 1 - - 1
Fertility 1 - 1 -
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin, T3 thyronine, T4 thyroxine, salivary C
salivary cortisol, salivary T salivary testosterone, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio, fertility evaluation by semen analysis
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lack of studies described by the latest guidelines [1].
Regarding endurance exercises, despite the potentially
high prevalence of OTS/NFOR/FOR among triathlon
athletes, only six studies performed tests in this popula-
tion, whereas other sports which OTS/NFOR/FOR has
been less described have been perhaps disproportion-
ately studies.
Unlike in endurance sports, that showed reduction in
catecholamines levels, an increase was observed in weight
lifters affected by OTS/NFOR, as seen in the three studies
that were performed in resistive athletes (weight-lifters),
which distinct results could be observed from the other
studies, once the two studies that evaluated catecholamines
found increased levels, and decreased beta-receptor
concentrations (down-regulation) in muscles were found in
one, with consequent decreased sensitivity to catechol-
amines. This finding is corroborated by Fry et al. [17],
whose correlation coefficients suggested decreased respon-
sivity of skeletal muscle to sympathetic nervous system ac-
tivity and therefore corroborates the sympathetic aspect of
the resistive FOR. Therefore, the named sympathetic OTS/
NFOR/FOR for resistive athletes [1, 39] may be appropri-
ate, although further studies are necessary to corroborate
these findings. as there is a lack of previous controlled
studies with resistive exercises.Hormones and OTS/NFOR/FOR
Establishment of cutoffs
Cutoffs developed for hormone levels as OTS/NFOR/
FOR markers would thus be distinct from the cutoffs for
the normal ranges used to diagnose endocrine conditions
(1,4,7,10,11), as frank low or high hormone levels lead to
diagnosis of endocrine dysfunction, which initially exclude
OTS/NFOR/FOR, and symptoms could be possibly ex-
plained by the underlying disease [1, 39]. Therefore,
regardless of the normal range, whenever athletes with
OTS/NFOR/FOR presented significantly different hormone
levels than healthy athletes, basal hormones would be able
to be good markers or predictors of OTS/NFOR/FOR, and
therefore cutoffs could be established using specific statis-
tics mechanisms.
Basal levels
Among all studies, basal levels of 17 tested hormones
(Table 6) were normal between affected and healthy ath-
letes in at least 75.0% of the studies for each hormone,
with the exceptions of plasma catecholamines, which was
performed in only two studies and found increased levels
in one (50.0%), and one study that employed IGFBP-3 and
found reduced levels. Therefore, none of the evaluated
basal hormone levels, nor the hormone-related parame-
ters, appear to be good predictors of OT/OR.
Table 7 Joint of acute hormone responses to stimulation tests and resting levels after induction of NFOR/FOR state
Hormone Quantity of studies Normal response Blunted response Exacerbated response
Cortisol 26 (65.0%) 18 (69.2%) 8 (30.8%) -
Total T 18 (45.0%) 14 (77.8%) 3 (16.7%) 1 (5.9%)
GH 13 (32.5%) 7 (53.8%) 5 (38.4%) 1 (7.8%)
T/C 10 (25.0%) 5 (50.0%) 4 (40.0%) 1 (10.0%)
ACTH 10 (25.0%) 6 (60.0%) 4 (40.0%) -
Plasma catecholamines 9 (22.5%) 4 (44.4%) 4 (44.4%) 1 (11.1%)
Insulin 8 (20.0%) 6 (75.0%) 2 (25.0%) -
LH 8 (20.0%) 7 (87.5%) 1 (12.5%) -
Prolactin 6 (15.0%) 4 (66.7%) 2 (33.3%) -
FSH 6 (15.0%) 5 (83.3%) 1 (16.7%) -
IGF-1 5 (12.5%) 3 (60.0%) 1 (20.0%) 1 (20.0%)
Aldosterone 5 (12.5%) 1 (20.0%) 2 (40.0%) 2 (40.0%)
Free T 3 (7.5%) 1 (33.3%) 1 (33.3%) 1 (33.3%)
T4 2 (5.0%) 2 (100%) - -
T3 2 (5.0%) 2 (100%) - -
NUC 2 (5.0%) - 2 (100%) -
Salivary C 2 (5.0%) - 2 (100%) -
Salivary T 2 (5.0%) 1 (50.0%) 1 (50.0%) -
NUC 2 (5.0%) 1 (50.0%) 1 (50.0%) -
IGFBP-3 2 (5.0%) 1 (50.0%) 1 (50.0%) -
IGF-1/IGFBP-3 2 (5.0%) 2 (100%) - -
SHBG 1 1 - -
DHEA-S 1 1 - -
Peptide F 1 1 - -
Fertility 1 - 1 -
Beta-2 muscle receptors 1 - 1 -
NUC Nocturnal urinary catecholamines, T/C testosterone/cortisol ratio, T/SHBG testosterone/sex hormone binding globulin, T3 thyronine, T4 thyroxine, salivary C
salivary cortisol, salivary T salivary testosterone, IGF-1/IGFBP-3 IGF-1/IGFBP3 ratio, fertility evaluation by semen analysis
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Resting levels performed in NFOR/FOR-induced athletes
are hormones that are measured after a night sleep in
the same conditions as the basal hormones, in subjects
that are induced for NFOR/FOR states after an overload
training period, as part of the study intervention, and
were demonstrated to show decrement in performance
capacity. Herein, 24 studies employed this method, and
normal levels were seen in all parameters, except for T/C
ratio, which was successful to show altered ratios
compared to healthy athletes in 50.0% of the studies
(40.0% showed reduced ratios and 10.0% showed in-
creased ratios), while normal findings were observed
in 50.0%.
When analyzed together, basal and resting hormones
were mostly normal, once none of the parameters were
shown to be altered in more than 50.0% of the selected
articles, whenever three or more studies were found for
the analyzed marker.Stimulated hormone responses as markers of OTS/NFOR/FOR
In contrast to basal levels, blunted hormone acute re-
sponses were seen in OTS/NFOR/FOR athletes, notably in
prolactin (67.1% of the studies), in GH (57.1%) and in
ACTH (57.1%) levels, whereas conflicting results in plasma
catecholamines (50.0% of responses were blunted, 25.0%
were increased and 25.0% normal) and in cortisol responses
(54.6% of tests were normal and 45.4% were blunted), in
comparison to healthy subjects. Notably, acute blunted
responses were observed regardless of the type of tests per-
formed, although most employed tests were not validated
or supported by endocrine societies. Therefore, further
studies are necessary to establish reliable markers and spe-
cific cutoffs for each potentially accurate marker.
The role of hormones in overtraining and overreaching
syndromes
The lack of alterations in basal and resting levels in
OTS/NFOR/FOR athletes may be explained by the high
Table 8 Results according to tests performed and subjects
analyzed
Parameter FOR-induced athletes Previously affected
subjects
Cortisol Normal results – 11 (68.8%)
Reduced levels – 5 (31.2%)
Total - 16
Normal results – 7 (50%)
Increased levels – 2 (14.3%)
Reduced levels – 5 (35.7%)
Total - 14
ACTH Normal results – 3 (100%) Normal results – 6 (46.2%)
Increased levels – 2 (15.3%)
Reduced levels – 5 (38.5%)
Total – 13
Serum
catecholamines
Normal results – 4 (66.7%)
Reduced levels – 2 (33.3%)
Total - 6
Normal results – 1 (20.0%)
Increased levels – 2 (40.0%)
Reduced levels – 2 (40.0%)
Total – 5
GH Normal results – 5 (100%)
Total - 5
Normal results – 1 (12.5%)
Increased levels – 2 (25.0%)
Reduced levels – 5 (62.5%)
Total - 8
T/c Normal results – 5 (62.5%)
Reduced levels – 3 (37.5%)
Total - 8
Normal results – 1 (33.3%)
Increased levels – 1 (33.3%)
Reduced levels – 1 (33.3%)
Total - 3
SHBG - Increased levels – 1 (100%)
IGF-1 Normal results – 1 (50.0%)
Reduced levels – 1 (50.0%)
Total - 2
Normal results – 1 (33.3%)
Increased levels – 2 (66.7%)
Total - 3
Free T Normal results – 1 (50.0%)
Increased levels – 1 (50.0%)
Total - 2
Reduced levels – 1 (100%)
Salivary C - Reduced levels – 2 (100%)
Salivary T - Increased levels – 1 (50.0%)
Reduced levels – 1 (50.0%)
Total T Normal results – 11 (78.6%)
Increased levels – 1 (7.1%)
Reduced levels – 2 (14.3%)
Total - 14
Normal results – 1 (33.3%)
Reduced levels – 2 (66.7%)
Total - 3
Insulin Normal results – 6 (85.7%)
Reduced levels – 1 (14.3%)
Total - 7
Normal results – 4 (80.0%)
Reduced levels – 1 (20.0%)
Total - 5
NUC Increased levels – 1 (25.0%)
Reduced levels – 3 (75.0%)
Total - 4
Normal results – 2 (100%)
IGFBP-3 - Reduced levels – 1 (100%)
IGF-1/IGFBP-3 - Increased levels – 1 (100%)
Prolactin Normal results – 4 (66.7%)
Reduced levels – 2 (33.3%)
Total - 6
Normal results – 1 (50.0%)
Reduced levels – 1 (50.0%)
Total - 2
LH Normal results – 6 (85.7%)
Reduced levels – 1 (14.3%)
Total – 7
-
FSH Normal results – 4 (80.0%)
Reduced levels – 1 (20.0%)
Total - 5
-
Aldosterone Normal results – 1 (16.7%)
Increased levels – 2 (33.3%)
Reduced levels – 3 (50.0%)
Total - 6
-
DHEA-S Normal results – 1 (100%) -
Peptide F - Normal results – 1 (100%)
Table 8 Results according to tests performed and subjects
analyzed (Continued)
Fertility Reduced levels – 1 (100%) -
TSH Normal results – 4 (100%) -
T4 L Normal results – 2 (100%) -
T3 L Normal results – 2 (100%) -
16 h salivary C Increased levels – 1 (100%) -
Beta2 muscle
receptor
Reduced levels – 1 (100%) -
Total number
of studies
21 (55.3%) 17 (44.7%)
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which leads to shorter periods of recovery after physical
exertion. The basal hormone release may not be altered
in these subjects, distinctly from the possible impaired
capacity to respond to stressful situations.
Indeed, despite of the limitations found in this systematic
review, the consistent findings of blunted ACTH, GH and
prolactin levels observed in all stimulation tests deserve
attention. Hormones and glands physiology present similar-
ities among them in terms of basal and stimulated hor-
mone production and release. In this case, initial stages of
glands dysfunctions tend to preserve basal hormone pro-
duction, but present impaired responses to stimulations,
such as stressful situations. Hormonal alterations may be
therefore only seen in acute responses to functional tests,
but not in basal and in resting levels, as observed in relative
adrenal insufficiency, GH deficiency and pre-diabetes and
initial diabetes. Relative adrenal insufficiency shows as a
lack of enough raise in cortisol levels to ITT or to ACTH-
stimulation test; GH deficiency is diagnosed when a blunted
GH is observed to ITT; and pre-diabetes or initial diabetes
are more accurately diagnosed by Oral Glucose Tolerance
Test, which provides earlier information about disglycemia
than fasting serum glucose, once relative hypoinsulinemia
with consequent hyperglycemia in response to oral glucose
is observed. In fact, severe adrenal insufficiency and final
stage of diabetes are required to present basal hypocortiso-
lism and fasting hyperglycemia with inappropriate hypoin-
sulinemia, respectively. TRH stimulation test for thyroid
function and LHRH stimulation test for ovary function are
able to show depletion of these glands prior to basal levels
as well. Therefore, it is possible, if not probable, that com-
promised glands with relative hormone dysfunction are
present in OTS, although further studies are required,
particularly linking acute hormonal responses to exercises
with functional tests standardized by endocrine societies.
Notably, hormonal changes in OTS/NFOR/FOR are
probably not triggers of these disorders, but may play a
role in the worsening and perpetuation of OTS/NFOR/
FOR symptoms. Thus once identified as markers, hor-
mones should not be replaced; instead, their recovered
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NFOR/FOR. Additionally, once basal levels are altered, a
diagnosis of OTS/NFOR/FOR is unlikely, as these condi-
tions should not be diagnosed in the presence of endo-
crine alterations [1, 4, 28].
Although acute responses to stress in OTS/NFOR/
FOR athletes and resting levels responses to NFOR/FOR
state were also analyzed together, they may present distinct
results, once they were measured in different situations,
allied to the fact that OTS may differ biochemically from
NFOR/FOR states. Indeed, one study showed different
results between OTS and NFOR/FOR [9], once in OTS,
GH and ACTH failed to raise in response to a TBE,
whereas in NFOR/FOR athletes both hormones markedly
raised in response to TBE. It was also observed that studies
with previously affected athletes tend to show more pro-
nounced altered responses than studies that induces FOR/
NFOR, perhaps due to the above-mentioned possible differ-
ence between FOR (when overload is performed, a FOR/
NFOR state is induced, not OTS) and OTS (most studies
with previously affected subjects tended to include OTS,
not FOR/NFOR athletes).
Differential diagnosis
Many dysfunctions that may confound the proper OTS/
NFOR/FOR diagnoses have to be excluded in athletes
that also lead to worsened performance and fatigue, includ-
ing: 1. Sleep disorders; 2. Site-specific or sub-clinical diffuse
inflammation (non-alcoholic steatohepatitis – NASH,
metabolic syndrome, dyslipidemia); 3. Frank hormonal
dysfunctions; 4. Autoimmune diseases (rheumatoid arth-
ritis, systemic lupus erythematosus, ankylosing spondylitis);
5. Vitamins deficiency (vitamin B12, B1, D); 6. Psychiatric
conditions (bipolar disorder, depression, anxiety disorders);
7. Lung dysfunctions (asthma, idiopathic pulmonary fibro-
sis, tuberculosis) and 8. Heart conditions (persistence space
of double interatrial septum, heart failure) Most of the
above listed differential diagnosis are not explicitly exposed
in the latest OTS/NFOR/FOR guideline [1].
Fatigue is not always linked to reduced performance,
and hormonal differences may be observed between non-
reduced performance and reduced-performance fatigued
athletes. Aubry et al. [2] compared athletes acutely fatigued
without decrement of performance and FOR athletes, and
catecholamines were found to be reduced in FOR com-
pared to the non-FOR fatigued subjects.
Hormonal markers of OTS/NFOR/FOR: Specific for these
conditions?
Some alterations found in OTS/NFOR/FOR athletes may
be resulted from overload training, regardless of the per-
formance state, and therefore be also observed in healthy
athletes. Indeed, Uusital et al. [28] performed an Experi-
mental Training Group (ETG) with massively intenseexercises (above lactate threshold) compared to control
group. Cortisol and noradrenaline were decreased in the
ETG in both induced FOR (n = 5) and non-FOR (n = 4),
compared to control, which means that altered findings
may not always differentiate OTS/NFOR/FOR, but indi-
cate an excess of training. The proposed markers of OTS/
NFOR/FOR were also contested by Hoogeveen et al. [30],
who showed that hormonal changes were the same
between OTS and healthy athletes, concluding that all the
alterations were related to physiological adaptions, not to
reduced sports performance.
Furthermore, despite of the systematic search for de-
creased total T and T/C ratio as markers of worsened per-
formance, Hoogeveen et al. [30] showed that decreased
total T, increased cortisol and decreased T/C ratio failed
to predict reduction in performance.
Limitations
Some remarkable limitations in studies that evaluated
hormonal levels in OTS/NFOR/FOR were: 1) The impos-
sibility of performing a meta-analyses owing to the wide
variety of methodologies; 2) Wide variety of evaluated
sports; 3) Lack of standardization criteria to differentiate
between OTS, NFOR and FOR; 4) Lack of enough studies
comparing OTS/NFOR/FOR with healthy athletes and
healthy sedentary individuals, in order to evaluate physio-
logical hormone adaption via training; 5) Small numbers
of participants in most studies; 6) Lack of studies with
sympathetic OTS/NFOR/FOR (such as in weight-lifters);
and 7) Lack of standardized stimulation tests endorsed by
endocrinology societies, to enforce the evidence strength.
Besides the limitations of the selected studies, this sys-
tematic review also presented some limitations. First, if the
basic PRISMA protocol of search for systematic reviews
was followed, only 12 studies would have been selected.
Therefore, an expanded search that went beyond an usual
systematic review had to be performed. Second, a more
comprehensive analysis for more precise conclusions was
unable to be performed, due to the unexpected differences
in methodology, even when types of sports or tests were
similar. And third, we found less consistent data then
expected, which did not allow a more complete systematic
review in the field.
Final discussion
To date, this is the first systematic review that evaluated
hormonal aspects of OTS./NFOR/FOR. The large number
of studies that compared basal levels between affected and
healthy athletes may lead to the conclusion that basal
levels of hormones are definitely not good markers of
OTS/NFOR/FOR. Conversely, stimulated hormones,
particularly acute responses to stressful conditions may
be good predictors of underperformance syndromes,
although OTS/NFOR/FOR is a complex disorder, with
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dysfunctions are unlikely to be the only etiology of OTS/
NFOR/FOR.
The overall conflicting findings of the present systematic
review reflects the complex relation between hormones
and overtraining syndrome. The main issue regarding hor-
mone findings in OTS is the causality relationship and the
real underlying reason that leads to decreased perform-
ance. Whenever the hormone dysfunction is likely the
primary cause for the worsened performance, OTS is ex-
cluded, once OTS requires exclusion of endocrine disor-
ders to be diagnosed. Conversely, OTS may lead to
dysfunctional hormones, as observed [1–38], and identify-
ing whether these dysfunctions are secondary to OTS is
challenging. As endocrinologists, we stated that generally,
whenever a frank and severe hormone dysfuncion was
found, the diagnosis of OTS is unlikely, once OTS tend to
induce mild changes in hormone, not important changes,
and since the hormone dysfuncion probably explains all
the clinical findings, and organic etiologies for the dysfun-
cion should be searched. Finally, who defines the diagnosis
is the underlying etiology: whenever the hormone dysfun-
cions do not fully explain the clinical presentation, and
seem to be a consequence of the OTS, OTS is the diagno-
sis; contrariwise, if the clinical presentation is attributable
to the hormone dysfunctions, the replacement or suppres-
sion of the affected hormone should be approached prior
to the diagnosis of OTS.
Finally, it may be too early to claim that GH, ACTH
and prolactin responses are undoubtedly blunted in
acute responses in affected individuals, once not all studies
found the same results, studies performed slightly different
protocols for ME and TBE, and small number of subjects
were included. For practical purposes, whenever an athlete
is suspected for OTS/NFOR/FOR, stimulation tests could
be performed in order to find possible relative failure of the
adrenals or the pituitary, although only standardized tests
by Endocrine societies (ITT) are enough to provide these
diagnosis.
Further studies should be performed with athletes
from the sports that are mostly described in OTS/
NFOR/FOR, such as triathlon, cycling and long distance
runners, standardization of ME should be employed,
both ME and ITT should be performed and correlated,
and a specific control group of healthy athletes that
practice the equivalent intensity and volume of training
should also perform the exact same tests, to strength the
level of the found data.
Conclusion
Acute hormone responses to stimulation tests, such as
ACTH, GH and prolactin, tend to be blunted in OTS/
NFOR/FOR, whereas cortisol and plasma catecholamines
presented conflicting results, and other hormonal acuteresponses were not systematically analyzed. The most per-
formed stimulation test was ME, differently from what the
latest guidelines on OTS/NFOR/FOR stated. The dysfunc-
tional responses observed in different sorts of stimulation
tests may demonstrate a relative failure of hormonal axis.
Contrariwise, basal and resting parameters do not seem to
play an accurate tool for OTS/NFOR/FOR diagnosis.
Despite of these conclusions, further studies are needed
in order to improve hormonal markers accuracy and cut-
offs. This systematic review will help future studies to draw
more specific targets and accurate methods.
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